BRIEF-Mylan says no comment at this point on U.S. generic Advair application
March 29 Mylan:
* Spokeswoman says company has no comment at this point on its U.S. FDA application for generic copy of GlaxoSmithKline's Advair
* For more on this story see Further company coverage: (Reporting by Ben Hirschler)